Versor Investments LP Purchases 5,401 Shares of Humana Inc. $HUM

Key Points

• Versor Investments LP increased its stake in Humana Inc. by 159.0% during the first quarter, now owning a total of 8,798 shares valued at approximately $2.33 million.
• Humana reported earnings per share of $6.27 for the last quarter, missing estimates and showing a 9.6% year-over-year revenue growth at $32.39 billion.
• Analysts have given Humana a range of ratings, with seventeen rating the stock as a hold and an average price target of $281.43.

Versor Investments LP raised its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 159.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,798 shares of the insurance provider's stock after acquiring an additional 5,401 shares during the quarter. Versor Investments LP's holdings in Humana were worth $2,328,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently modified their holdings of HUM. Revolve Wealth Partners LLC bought a new stake in Humana during the 4th quarter worth approximately $202,000. Mariner LLC grew its position in shares of Humana by 4.0% during the fourth quarter. Mariner LLC now owns 13,461 shares of the insurance provider's stock worth $3,415,000 after purchasing an additional 517 shares in the last quarter. Insigneo Advisory Services LLC grew its stake in Humana by 17.3% during the fourth quarter. Insigneo Advisory Services LLC now owns 1,360 shares of the insurance provider's stock valued at $345,000 after acquiring an additional 201 shares in the last quarter. Forum Financial Management LP lifted its stake in Humana by 62.0% in the 4th quarter. Forum Financial Management LP now owns 1,916 shares of the insurance provider's stock worth $486,000 after purchasing an additional 733 shares in the last quarter. Finally, First Trust Advisors LP boosted its holdings in shares of Humana by 78.6% during the 4th quarter. First Trust Advisors LP now owns 93,328 shares of the insurance provider's stock valued at $23,678,000 after purchasing an additional 41,070 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms recently commented on HUM. Piper Sandler decreased their target price on Humana from $288.00 to $272.00 and set a "neutral" rating on the stock in a research report on Thursday, July 31st. Wall Street Zen downgraded Humana from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. Raymond James Financial upgraded shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price target on the stock in a research report on Thursday, May 1st. Truist Financial decreased their price target on shares of Humana from $280.00 to $260.00 and set a "hold" rating on the stock in a research note on Wednesday, July 16th. Finally, Morgan Stanley dropped their price objective on shares of Humana from $290.00 to $277.00 and set an "equal weight" rating for the company in a research note on Thursday, July 31st. Seven equities research analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $281.43.

Humana Trading Up 0.6%

Shares of HUM traded up $1.8540 during mid-day trading on Wednesday, reaching $290.1040. 1,247,722 shares of the company's stock traded hands, compared to its average volume of 1,729,720. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. The stock's 50-day moving average is $244.92 and its two-hundred day moving average is $253.44. Humana Inc. has a 12 month low of $206.87 and a 12 month high of $382.72. The stock has a market cap of $34.89 billion, a P/E ratio of 22.26, a P/E/G ratio of 1.69 and a beta of 0.44.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). The business had revenue of $32.39 billion for the quarter, compared to analysts' expectations of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. Humana's revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.96 EPS. Humana has set its FY 2025 guidance at 17.000- EPS. Research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.